A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.

Feldman HH, Cummings JL, Boxer AL, Staffaroni AM, Knopman DS, Sukoff Rizzo SJ, Territo PR, Arnold SE, Ballard C, Beher D, Boeve BF, Dacks PA, Diaz K, Ewen C, Fiske B, Gonzalez MI, Harris GA, Hoffman BJ, Martinez TN, McDade E, Nisenbaum LK, Palma JA, Quintana M, Rabinovici GD, Rohrer JD, Rosen HJ, Troyer MD, Kim DY, Tanzi RE, Zetterberg H, Ziogas NK, May PC, Rommel A.

Open source

DOI
10.1002/alz.14250
Published
2024-09-24
Container
Alzheimers Dement
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/alz.14250,
  title = {A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.},
  author = {Feldman HH and  Cummings JL and  Boxer AL and  Staffaroni AM and  Knopman DS and  Sukoff Rizzo SJ and  Territo PR and  Arnold SE and  Ballard C and  Beher D and  Boeve BF and  Dacks PA and  Diaz K and  Ewen C and  Fiske B and  Gonzalez MI and  Harris GA and  Hoffman BJ and  Martinez TN and  McDade E and  Nisenbaum LK and  Palma JA and  Quintana M and  Rabinovici GD and  Rohrer JD and  Rosen HJ and  Troyer MD and  Kim DY and  Tanzi RE and  Zetterberg H and  Ziogas NK and  May PC and  Rommel A.},
  year = {2024},
  journal = {Alzheimers Dement},
  doi = {10.1002/alz.14250},
  url = {https://doi.org/10.1002/alz.14250}
}

RIS

TY  - JOUR
TI  - A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.
AU  - Feldman HH
AU  -  Cummings JL
AU  -  Boxer AL
AU  -  Staffaroni AM
AU  -  Knopman DS
AU  -  Sukoff Rizzo SJ
AU  -  Territo PR
AU  -  Arnold SE
AU  -  Ballard C
AU  -  Beher D
AU  -  Boeve BF
AU  -  Dacks PA
AU  -  Diaz K
AU  -  Ewen C
AU  -  Fiske B
AU  -  Gonzalez MI
AU  -  Harris GA
AU  -  Hoffman BJ
AU  -  Martinez TN
AU  -  McDade E
AU  -  Nisenbaum LK
AU  -  Palma JA
AU  -  Quintana M
AU  -  Rabinovici GD
AU  -  Rohrer JD
AU  -  Rosen HJ
AU  -  Troyer MD
AU  -  Kim DY
AU  -  Tanzi RE
AU  -  Zetterberg H
AU  -  Ziogas NK
AU  -  May PC
AU  -  Rommel A.
PY  - 2024
JO  - Alzheimers Dement
DO  - 10.1002/alz.14250
UR  - https://doi.org/10.1002/alz.14250
ER  - 

APA

HH, F., JL, C., AL, B., AM, S., DS, K., SJ, S. R., PR, T., SE, A., C, B., D, B., BF, B., PA, D., K, D., C, E., B, F., MI, G., GA, H., BJ, H., TN, M., E, M., LK, N., JA, P., M, Q., GD, R., JD, R., HJ, R., MD, T., DY, K., RE, T., H, Z., NK, Z., PC, M., & A., R. (2024). A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.. Alzheimers Dement. https://doi.org/10.1002/alz.14250

Source records